Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK/STAT signaling

Yiya Yang1, Yuting Lei1, Yumei Liang1

  • 1Department of Nephrology and Laboratory of Kidney Disease, Changsha Clinical Research Center for Kidney DiseaseHunan Clinical Research Center for Chronic Kidney Disease, Hunan Provincial People's Hospital, Hunan Normal University, 61#, Jiefang West Road, Changsha, 410005, Hunan Province, People's Republic of China.

Abstract

Insights

Vitamin D (VD) protects kidney cells from high glucose damage by inhibiting the JAK/STAT pathway. This suggests VD is a potential treatment for diabetic nephropathy by reducing fibronectin production.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • High glucose (HG) triggers TGF-β and ROS production, activating JAK/STAT signaling.
  • This pathway promotes matrix protein synthesis, contributing to diabetic nephropathy (DN) pathogenesis.
  • Investigating protective agents against HG-induced kidney injury is crucial.

Purpose of the Study:

  • To investigate the protective role of vitamin D (VD) in kidney cells under high glucose conditions.
  • To elucidate the molecular mechanisms underlying VD's potential renoprotective effects.

Main Methods:

  • Rat glomerular mesangial cells were cultured in high glucose medium.
  • Cells were treated with VD or vitamin D receptor (VDR) siRNAs.
  • TGF-β, fibronectin, JAK/STAT pathway components, and downstream gene expression were analyzed using qRT-PCR, immunoblotting, and ELISA.

Main Results:

  • VD treatment suppressed tyrosine phosphorylation of JAK2, STAT1, and STAT3.
  • VD inhibited TGF-β and fibronectin expression, effects reversed by VDR siRNA and a STATs inhibitor.
  • VD repressed JAK/STAT downstream genes (SOCS1, SOCS3, type IV collagen) and modulated specific microRNAs (miR-181a/b downregulated, miR-34a/Let-7b upregulated).

Conclusions:

  • Vitamin D inhibits high glucose-induced fibronectin production via the JAK/STAT pathway.
  • VD demonstrates renoprotective effects by repressing JAK/STAT signaling in glomerular mesangial cells.
  • These findings support VD's potential as a therapeutic strategy for diabetic nephropathy.

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
319
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.9K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
5.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.2K